Advertisement

Telomeres and telomerase in cancer stem cells

  • Zhenyu Ju
    Affiliations
    Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Carl-Neuberg Str. 1, K11, E1, R1400/1370, 30625 Hannover, Germany
    Search for articles by this author
  • Karl Lenhard Rudolph
    Correspondence
    Corresponding author. Tel.: +511 5326999; fax: +511 5326998.
    Affiliations
    Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Carl-Neuberg Str. 1, K11, E1, R1400/1370, 30625 Hannover, Germany
    Search for articles by this author

      Abstract

      Alterations in telomere dynamics both suppress and facilitate malignant transformation by regulating genomic stability and cell lifespan. Checkpoints induced by telomere dysfunction play a major role in tumour suppression, whereas telomere shortening contributes to the initiation of cancer by inducing chromosomal instability. Since stem cells are exposed to various tumourigenic agents and stresses throughout their lifetime, the ageing stem cell is a major target of malignant transformation. This review summarises our knowledge of telomere length and telomerase activity in stem cells during ageing and carcinogenesis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Blackburn E.H.
        Structure and function of telomeres.
        Nature. 1991; 350: 569-573
        • Blasco M.A.
        • Lee H.W.
        • Hande M.P.
        • et al.
        Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.
        Cell. 1997; 91: 25-34
        • Blackburn E.H.
        Switching and signaling at the telomere.
        Cell. 2001; 106: 661-673
        • de Lange T.
        Protection of mammalian telomeres.
        Oncogene. 2002; 21: 532-540
        • Hackett J.A.
        • Feldser D.M.
        • Greider C.W.
        Telomere dysfunction increases mutation rate and genomic instability.
        Cell. 2001; 106: 275-286
        • Allsopp R.C.
        • Chang E.
        • Kashefi-Aazam M.
        • et al.
        Telomere shortening is associated with cell division in vitro and in vivo.
        Exp Cell Res. 1995; 220: 194-200
        • Levy M.Z.
        • Allsopp R.C.
        • Futcher A.B.
        • Greider C.W.
        • Harley C.B.
        Telomere end-replication problem and cell aging.
        J Mol Biol. 1992; 225: 951-960
        • Allsopp R.C.
        • Vaziri H.
        • Patterson C.
        • Goldstein S.
        • et al.
        Telomere length predicts replicative capacity of human fibroblasts.
        Proc Natl Acad Sci USA. 1992; 89: 10114-10118
        • Allsopp R.C.
        • Harley C.B.
        Evidence for a critical telomere length in senescent human fibroblasts.
        Exp Cell Res. 1995; 219: 130-136
        • Djojosubroto M.W.
        • Choi Y.S.
        • Lee H.W.
        • Rudolph K.L.
        Telomeres and telomerase in aging, regeneration and cancer.
        Mol Cells. 2003; 15: 164-175
        • Lee H.W.
        • Blasco M.A.
        • Gottlieb G.J.
        • Horner J.W.
        • Greider C.W.
        • DePinho R.A.
        Essential role of mouse telomerase in highly proliferative organs.
        Nature. 1998; 392: 569-574
        • Wright W.E.
        • Shay J.W.
        The two-stage mechanism controlling cellular senescence and immortalization.
        Exp Gerontol. 1992; 27: 383-389
        • Counter C.M.
        • Avilion A.A.
        • LeFeuvre C.E.
        • et al.
        Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
        EMBO J. 1992; 11: 1921-1929
        • Nakamura T.M.
        • Morin G.B.
        • Chapman K.B.
        • et al.
        Telomerase catalytic subunit homologs from fission yeast and human.
        Science. 1997; 277: 955-959
        • Meyerson M.
        • Counter C.M.
        • Eaton E.N.
        • et al.
        hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.
        Cell. 1997; 90: 785-795
        • Blasco M.A.
        • Rizen M.
        • Greider C.W.
        • Hanahan D.
        Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.
        Nat Genet. 1996; 12: 200-204
        • Satyanarayana A.
        • Manns M.P.
        • Rudolph K.L.
        Telomeres and telomerase: a dual role in hepatocarcinogenesis.
        Hepatology. 2004; 40: 276-283
        • Plentz R.R.
        • Caselitz M.
        • Bleck J.S.
        • et al.
        Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
        Hepatology. 2004; 40: 80-86
        • Plentz R.R.
        • Wiemann S.U.
        • Flemming P.
        • et al.
        Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer.
        Gut. 2003; 52: 1304-1307
        • Rudolph K.L.
        • Millard M.
        • Bosenberg M.W.
        • DePinho R.A.
        Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
        Nat Genet. 2001; 28: 155-159
        • Rudolph K.L.
        • Chang S.
        • Lee H.W.
        • et al.
        Longevity, stress response, and cancer in aging telomerase-deficient mice.
        Cell. 1999; 96: 701-712
        • Greenberg R.A.
        • Chin L.
        • Femino A.
        • et al.
        Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
        Cell. 1999; 97: 515-525
        • Gonzalez-Suarez E.
        • Samper E.
        • Flores J.M.
        • Blasco M.A.
        Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.
        Nat Genet. 2000; 26: 114-117
        • Artandi S.E.
        • Chang S.
        • Lee S.L.
        • et al.
        Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.
        Nature. 2000; 406: 641-645
        • d’Adda D.F.
        • Reaper P.M.
        • Clay-Farrace L.
        • et al.
        A DNA damage checkpoint response in telomere-initiated senescence.
        Nature. 2003; 426: 194-198
        • Kirk K.E.
        • Harmon B.P.
        • Reichardt I.K.
        • Sedat J.W.
        • Blackburn E.H.
        Block in anaphase chromosome separation caused by a telomerase template mutation.
        Science. 1997; 275: 1478-1481
        • Lengauer C.
        • Kinzler K.W.
        • Vogelstein B.
        Genetic instabilities in human cancers.
        Nature. 1998; 396: 643-649
        • O’Sullivan J.N.
        • Bronner M.P.
        • Brentnall T.A.
        • et al.
        Chromosomal instability in ulcerative colitis is related to telomere shortening.
        Nat Genet. 2002; 32: 280-284
        • Plentz R.R.
        • Schlegelberger B.
        • Flemming P.
        • et al.
        Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
        Hepatology. 2005; 42: 522-526
        • Takai H.
        • Smogorzewska A.
        • de Lange T.
        DNA damage foci at dysfunctional telomeres.
        Curr Biol. 2003; 13: 1549-1556
        • Satyanarayana A.
        • Greenberg R.A.
        • Schaetzlein S.
        • et al.
        Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling.
        Mol Cell Biol. 2004; 24: 5459-5474
        • Bartkova J.
        • Horejsi Z.
        • Koed K.
        • et al.
        DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
        Nature. 2005; 434: 864-870
        • Chin L.
        • Artandi S.E.
        • Shen Q.
        • et al.
        p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.
        Cell. 1999; 97: 527-538
        • Chin K.
        • de Solorzano C.O.
        • Knowles D.
        • et al.
        In situ analyses of genome instability in breast cancer.
        Nat Genet. 2004; 36: 984-988
        • Lechel A.
        • Satyanarayana A.
        • Ju Z.
        • et al.
        The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.
        EMBO Rep. 2005; 6: 275-281
        • Counter C.M.
        • Botelho F.M.
        • Wang P.
        • Harley C.B.
        • Bacchetti S.
        Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes.
        J Virol. 1994; 68: 3410-3414
        • Stewart S.A.
        Telomere maintenance and tumorigenesis: an ‘ALT’ernative road.
        Curr Mol Med. 2005; 5: 253-257
        • Gonzalez-Suarez E.
        • Samper E.
        • Ramirez A.
        • et al.
        Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.
        EMBO J. 2001; 20: 2619-2630
        • Artandi S.E.
        • Alson S.
        • Tietze M.K.
        • et al.
        Constitutive telomerase expression promotes mammary carcinomas in aging mice.
        Proc Natl Acad Sci USA. 2002; 99: 8191-8196
        • Li S.
        • Rosenberg J.E.
        • Donjacour A.A.
        • et al.
        Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.
        Cancer Res. 2004; 64: 4833-4840
        • Smith L.L.
        • Coller H.A.
        • Roberts J.M.
        Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.
        Nat Cell Biol. 2003; 5: 474-479
        • Li S.
        • Crothers J.
        • Haqq C.M.
        • Blackburn E.H.
        Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.
        J Biol Chem. 2005; 280: 23709-23717
        • Clark G.M.
        • Osborne C.K.
        • Levitt D.
        • Wu F.
        • Kim N.W.
        Telomerase activity and survival of patients with node-positive breast cancer.
        J Natl Cancer Inst. 1997; 89: 1874-1881
        • Albanell J.
        • Lonardo F.
        • Rusch V.
        • et al.
        High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
        J Natl Cancer Inst. 1997; 89: 1609-1615
        • Harley C.B.
        Telomerase therapeutics for degenerative diseases.
        Curr Mol Med. 2005; 5: 205-211
        • Lapidot T.
        • Sirard C.
        • Vormoor J.
        • et al.
        A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
        Nature. 1994; 367: 645-648
        • Bonnet D.
        • Dick J.E.
        Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
        Nat Med. 1997; 3: 730-737
        • Cozzio A.
        • Passegue E.
        • Ayton P.M.
        • Karsunky H.
        • Cleary M.L.
        • Weissman I.L.
        Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
        Genes Dev. 2003; 17: 3029-3035
        • So C.W.
        • Karsunky H.
        • Wong P.
        • Weissman I.L.
        • Cleary M.L.
        Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
        Blood. 2004; 103: 3192-3199
        • Passegue E.
        • Jamieson C.H.
        • Ailles L.E.
        • Weissman I.L.
        Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?.
        Proc Natl Acad Sci USA. 2003; 100: 11842-11849
        • Al Hajj M.
        • Clarke M.F.
        Self-renewal and solid tumor stem cells.
        Oncogene. 2004; 23: 7274-7282
        • Singh S.K.
        • Clarke I.D.
        • Terasaki M.
        • et al.
        Identification of a cancer stem cell in human brain tumors.
        Cancer Res. 2003; 63: 5821-5828
        • Zimmermann S.
        • Martens U.M.
        Telomere dynamics in hematopoietic stem cells.
        Curr Mol Med. 2005; 5: 179-185
        • Zimmermann S.
        • Glaser S.
        • Ketteler R.
        • Waller C.F.
        • Klingmuller U.
        • Martens U.M.
        Effects of telomerase modulation in human hematopoietic progenitor cells.
        Stem Cells. 2004; 22: 741-749
        • Engelhardt M.
        • Kumar R.
        • Albanell J.
        • Pettengell R.
        • Han W.
        • Moore M.A.
        Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.
        Blood. 1997; 90: 182-193
        • Vaziri H.
        • Dragowska W.
        • Allsopp R.C.
        • Thomas T.E.
        • Harley C.B.
        • Lansdorp P.M.
        Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
        Proc Natl Acad Sci USA. 1994; 91: 9857-9860
        • Vulliamy T.
        • Marrone A.
        • Goldman F.
        • et al.
        The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
        Nature. 2001; 413: 432-435
        • Mason P.J.
        • Wilson D.B.
        • Bessler M.
        Dyskeratosis congenita – a disease of dysfunctional telomere maintenance.
        Curr Mol Med. 2005; 5: 159-170
        • Herrera E.
        • Samper E.
        • Martin-Caballero J.
        • Flores J.M.
        • Lee H.W.
        • Blasco M.A.
        Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.
        EMBO J. 1999; 18: 2950-2960
        • Satyanarayana A.
        • Wiemann S.U.
        • Buer J.
        • et al.
        Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.
        EMBO J. 2003; 22: 4003-4013
        • Aladjem M.I.
        • Spike B.T.
        • Rodewald L.
        • et al.
        ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage.
        Curr Biol. 1998; 8: 145-155
        • Hong Y.
        • Stambrook P.J.
        Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation.
        Proc Natl Acad Sci USA. 2004; 101: 14443-14448
        • Ohyashiki J.H.
        • Sashida G.
        • Tauchi T.
        • Ohyashiki K.
        Telomeres and telomerase in hematologic neoplasia.
        Oncogene. 2002; 21: 680-687
      1. Ju Z, Rudolph KL. Telomeres and telomerase in stem cells during aging and disease. Genome dynamics, vol. 1: genome and disease; 2005.

        • Greenberg P.
        • Cox C.
        • LeBeau M.M.
        • Fenaux P.
        • et al.
        International scoring system for evaluating prognosis in myelodysplastic syndromes.
        Blood. 1997; 89: 2079-2088
        • Ladetto M.
        • Compagno M.
        • Ricca I.
        • et al.
        Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders.
        Blood. 2004; 103: 4644-4649
        • Ohyashiki K.
        • Ohyashiki J.H.
        • Iwama H.
        • Hayashi S.
        • Shay J.W.
        • Toyama K.
        Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
        Leukemia. 1997; 11: 190-194
        • Brummendorf T.H.
        • Rufer N.
        • Holyoake T.L.
        • et al.
        Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders.
        Ann NY Acad Sci. 2001; 938: 293-303
        • Brummendorf T.H.
        • Holyoake T.L.
        • Rufer N.
        • et al.
        Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.
        Blood. 2000; 95: 1883-1890
        • Ohyashiki J.H.
        • Iwama H.
        • Yahata N.
        • et al.
        Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
        Clin Cancer Res. 1999; 5: 1155-1160
        • Sieglova Z.
        • Zilovcova S.
        • Cermak J.
        • et al.
        Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?.
        Leuk Res. 2004; 28: 1013-1021
        • Mason P.J.
        • Wilson D.B.
        • Bessler M.
        Dyskeratosis congenita – a disease of dysfunctional telomere maintenance.
        Curr Mol Med. 2005; 5: 159-170
        • Engelhardt M.
        • Mackenzie K.
        • Drullinsky P.
        • Silver R.T.
        • Moore M.A.
        Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
        Cancer Res. 2000; 60: 610-617
        • Ohyashiki K.
        • Iwama H.
        • Yahata N.
        • et al.
        Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation.
        Leuk Lymphoma. 2001; 42: 291-299
        • Kiel M.J.
        • Yilmaz O.H.
        • Iwashita T.
        • Yilmaz O.H.
        • Terhorst C.
        • Morrison S.J.
        SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.
        Cell. 2005; 121: 1109-1121
        • Zimmermann S.
        • Voss M.
        • Kaiser S.
        • Kapp U.
        • Waller C.F.
        • Martens U.M.
        Lack of telomerase activity in human mesenchymal stem cells.
        Leukemia. 2003; 17: 1146-1149